FDA Approves Novo Nordisk's Long-Awaited Diabetes Drug 10.06.2015 22:52 PM The U.S. Food and Drug Administration on Friday approved Danish drugmaker Novo Nordisk's diabetes drug Tresiba, two years after rejecting the long-acting form of insulin.
Two Individuals Achieve First-Ever Communication Through Lucid Dreams While Sleeping At Separate Locations
SPACEVoyager 2’s Historic Uranus Flyby May Have Captured Rare Event, Changing Scientists’ View of the Planet
MEDICINE & HEALTHColorectal Cancer Deaths Increasing Among Millennials and Gen X: Learn the Warning Signs